“Respond, Recover and Reimagine are vital in any crisis and have often not been the focus of a preparation strategy”

Antonio De Castro, Senior Industry Consultant, Global Health and Life Sciences Practice, SAS Health, Singapore

- Hithaishi C Bhaskar

The impact of the pandemic is strengthening medical/clinical research analytics through digital transformation. In line with this, healthcare analytics frameworks are boosting safer and faster deliveries of novel therapies and vaccines across the drug development spectrum. Like the rest of the world, the Asia Pacific (APAC) region has not prioritised prevention over cure within healthcare. We have focused on treating illness when presented and managed a demand-based healthcare prioritisation. The current COVID-19 crisis has shown that resources that are allocated in this way can be rapidly overwhelmed when demand spikes occur. Modern health service can be accelerated by appropriately utilising capabilities in healthcare analytics. Locating and accurately calibrating resource availability is the key to expedite health services for efficient deployment of medical devices, patient data, clinical progress and many more. Antonio De Castro, Senior Industry Consultant, Global Health and Life Sciences Practice at SAS Health, Singapore shares complete insight into healthcare data analytics. Edited excerpts;

What’s the role of an analytical framework in personalised healthcare solutions? How can APAC better expand analytical horizons to accelerate healthcare practices?

A healthcare analytics system enables the balance among users, equipment and consumables. Crucial data such as the proportion of medical devices and actual number in use, accountability of trained staffs with healthcare device handling capabilities, stationing of medical staffs and devices, consumables deployed and further needed, all can be efficiently managed by installing advanced predictive analytics to accelerate healthcare success.